Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 19, Issue 1, 2000, Pages 53-56

  Cimon, B ^a   Carrere J ^b   Vinatier, J F ^a   Chazalette, J P ^b   Chabasse, D ^a   Bouchara, J P ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b Hopital Renee Sabran   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; CHILD; COUNTER IMMUNOELECTROPHORESIS; CROSS REACTION; CYSTIC FIBROSIS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MYCOSIS; PRIORITY JOURNAL; SCEDOSPORIUM APIOSPERMUM; SENSITIZATION; SERODIAGNOSIS; SPUTUM CULTURE; SYMPTOM;

EID: 0033952695     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050011     Document Type: Article

References (16)

1. 1. Dupont B, Improvisi L, Ronin O: Aspects épidémiologiques et cliniques des infections à Scedosporium et à Pseudallescheria. Journal de Mycologie Médicale (1991) 1:33-42
2. 2. Rippon JW: Pseudallescheriasis. In: Rippon JW (ed): Medical mycology. The pathogenic fungi and the pathogenic Actinomycetes. WB Saunders, Philadelphia (1988) pp 651-680
3. 3. Bakerspigel A, Schaus D: Petriellidiosis (pseudallescheriasis) in southwestern Ontario, Canada. Sabouraudia (1984) 22:247-249
4. 4. Chabasse D, Bouchara JP, Chazalette JP, Carrère J, Giniès JL, de Gentile L, Cimon B: Mucoviscidose et colonisation fongique à Scedosporium apiospermum. A propos de trois observations. Journal de Mycologie Médicale (1991) 1:172-174
5. 5. Cimon B, Carrère J, Chazalette JP, Giniès JL, Six P, Vinatier JF, Chabasse D, Bouchara JP: Fungal colonization and immune response to fungi in cystic fibrosis. Journal de Mycologie Médicale (1995) 5:211-216
6. 6. De Hoog GS, Guarro J: Atlas of clinical fungi. Centraal-bureau Voor Schimmelcultures, Baarn and Delft, The Netherlands; Universitat Rovira i Virgili, Reus, Spain (1995) p 720
7. 7. Kurup VP, Fink JN: Evaluation of methods to detect antibodies against Aspergillus fumigatus. American Journal of Clinical Pathology (1978) 69:414-417
8. 8. Blaschke-Hellmessen R, Spitzer H, Paul KD, Hoffman C: Mykologische Überwachung von Kindern mit Mukoviszidose. Mycoses (1991) 34:43-47
9. 9. Beguin H, Nolard N: Mould biodiversity in homes. Air and surface analysis of 130 dwellings. Aerobiologia (1994) 10:157-166
10. 10. Gilligan PH: Microbiology of airway disease in patients with cystic fibrosis. Clinical Microbiology Reviews (1991) 4:35-51
11. 11. Larcher G, Cimon B, Symoens F, Tronchin G, Chabasse D, Bouchara JP: A 33 kDa serine proteinase from Scedosporium apiospermum. Biochemical Journal (1996) 315:119-126
12. 12. Konstan MW, Berger M: Infection and inflammation of the lung in cystic fibrosis. In: Davis PB (ed): Lung biology in health and disease. Cystic fibrosis. Marcell Dekker, New York (1993) pp 219-275
13. 13. Hennequin C, Benailly N, Silly C, Sorin M, Scheinmann P, Lenoir G, Gaillard JL, Berche P: In vitro susceptibilities to amphotericin B, itraconazole, and miconazole of filamentous fungi isolated from patients with cystic fibrosis. Antimicrobial Agents and Chemotherapy (1997) 41:2064-2066
14. 14. Elliott MW, Newman Taylor AJ: Allergic bronchopulmonary aspergillosis. Clinical and Experimental Allergy (1997) 27:55-59
15. 15. Miller MA, Greenberger PA, Amerian R, Toogood JH, Noskin GA, Roberts M, Patterson R: Allergic bronchopulmonary mycosis caused by Pseudallescheria boydii. American Review of Respiratory Diseases (1993) 148:810-812
16. 16. Lake FR, Tribe AE, McAleer R, Froudist J, Thompson PJ: Mixed allergic bronchopulmonary fungal disease due to Pseudallescheria boydii and Aspergillus. Thorax (1990) 45:489-492